Main baseline characteristics of participants.

<p>Of type 2 diabetic subjects, 12 were receiving other hypoglycaemic treatments. SD: Standard Deviation; IQR: Inter-Quartile Range;</p>£<p>Diabetes was assessed for subjects with fasting blood glucose ≥7.7 mmol/l (140 mg/dl) or under hypoglycaemic drug treatment;</p>££<p>Diabetic subjects treated with metformin alone;</p>£££<p>Diabetics with sulfonylureas or insulin alone or in combination;</p><p>* Diabetes with renal, ophthalmic, neurological, peripheral arterial disease or atherosclerotic cardiovascular disease;</p><p>** Among diabetics.